Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Int J Cardiol. 2023 Nov 26;398:131610. doi: 10.1016/j.ijcard.2023.131610

TABLE 1.

Baseline characteristics according to CRP levels at admission, day 3 and 14 after STEMI, divided according to the cut-off at the different time points.

Admission CRP (mg/L) (n=129) CRP at day 3 (mg/L) (n=124) CRP at day 14 (mg/L) (n=115)
≥ 6.45 (n=47) < 6.45 (n=82) P Value ≥ 26 (n=32) < 26 (n=92) P Value ≥ 9.56 (n=26) < 9.56 (n=89) p Value
Age, years (Median, IQR) 54 [46–59] 56 [54–63] 0.12 55 [48–61] 55 [49–63] 0.91 56 [43–62] 56 [49–63] 0.64
Women (%) 16 9 0.001 26 75 0.97 20 73 0.56
Black Americans (%) 22 25 0.06 11 32 0.97 11 29 0.36
Diabetes mellitus (%) 16 22 0.39 9 27 0.89 7 25 0.91
Hypertension (%) 29 49 0.83 21 56 0.63 16 56 0.94
Dyslipidemia (%) 27 42 0.49 17 48 0.93 11 51 0.18
Smoker (%) 28 45 0.60 18 52 0.98 14 50 0.83
BMI, kg/m2 (Median, IQR) 33.5 [28.6–36.8] 28.3 [24.9–33.5] 0.003 28.9 [27.2–34.2] 30.2 [25.6–34.9] 0.84 33.0 [28.3–41.0] 28.7 [25.1–34.2] 0.02
Symptoms onset to PCI, min (Median, IQR) 165 [124–360] 157 [97–307] 0.43 177 [107–330] 161 [105–356] 0.91 184 [127–381] 154 [107–356] 0.47
Admission CRP, mg/L (Median, IQR) 11.1 [8.4–16.6] 3.3 [1.5–4.6] 0.0001 6.6 [3.1–12.6] 4.4 [2.3–7.5] 0.05 9.3 [6.5–14.6] 3.9 [2.1–6.4] <0.001

CRP=C-reactive protein; STEMI=ST-segment elevation myocardial infarction; BMI=body mass index; PCI= percutaneous coronary intervention; IQR=interquartile range.